Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1256359-21-3 | MDL No. : | MFCD11858368 |
Formula : | C16H20BNO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MOQAIXOQKOUHGG-UHFFFAOYSA-N |
M.W : | 301.15 | Pubchem ID : | 53217131 |
Synonyms : |
|
Num. heavy atoms : | 22 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.44 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 86.05 |
TPSA : | 60.55 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.06 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.92 |
Log Po/w (WLOGP) : | 2.25 |
Log Po/w (MLOGP) : | 1.31 |
Log Po/w (SILICOS-IT) : | 2.36 |
Consensus Log Po/w : | 1.77 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.65 |
Solubility : | 0.0672 mg/ml ; 0.000223 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.85 |
Solubility : | 0.0423 mg/ml ; 0.00014 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.95 |
Solubility : | 0.00339 mg/ml ; 0.0000113 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.11 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium carbonate In 1,4-dioxane for 2h; Inert atmosphere; Reflux; | General Method 4 - representative procedure (0904) Methyl 2-(4-amino- 1-isopropyl- 1H-pyrazolo[3, 4-d]pyrimidin-3-yl)- 1 H-indole-6-carboxylate (Intermediate 27) (0905) [00215] A mixture of 3-bromo-1-isopropyl-1 /-/-pyrazolo[3,4-d]pyrimidin-4-amine (0.4 g, 1.56 mmol) and methyl 2-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)-1 /-/-indole-6- carboxylate (0.47 g, 1.56 mmol) in 1 ,4-dioxane (10 mL) was degassed with nitrogen. Pd(dppf)CI2 DCM (32 mg, 0.04 mmol) was added followed by 1.8 M K2C03 (1.74 mL, 3.12 mmol). The reaction mixture was heated at reflux for 2 hours then cooled to room temperature, diluted with EtOAc (50 mL) and washed with water (2 χ 25 mL). The combined aqueous phases were back-extracted with EtOAc (50 mL). The combined organics were washed with brine (50 mL) then concentrated in vacuo and purified by fee (0-100% EtOAc in isohexane) to return the title compound (438 mg, 80%) as a yellow solid. LCMS [M+H]+ 351.2; 1 H NMR (300 MHz, DMSO-de) δ 1 1.98 (br s, 1 H), 8.28 (s, 1 H), 8.15 (s, 1 H), 7.65-7.74 (m, 2H), 7.16 (br s, 1 H), 6.96 (s, 1 H), 5.12 (quin, J = 6.64 Hz, 1 H), 3.88 (s, 3H), 1.55 (d, J = 6.78 Hz, 6H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: potassium carbonate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / 1,4-dioxane / 2 h / Inert atmosphere; Reflux 2: N-chloro-succinimide / N,N-dimethyl-formamide / 1 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In 1,4-dioxane; water at 80℃; for 1.5h; Inert atmosphere; | 86.1 Step 1: Preparation of methyl 2-(6-(3-((tert-butyldimethylsilyl)oxy)propyl)-4-((2,4- dimethoxybenzylamino-7-isopropyl-7H-pyrrolo[2.3-dlpyrimidin-5-yl-lH-indole-6-carboxylate. A mixture of 6-(3-((tert-butyldimethylsilyl)oxy)propyl)-N-(2,4-dimethoxybenzyl)-5-iodo-7-isopropyl-7H- pyrrolo[2,3-d]pyrimidin-4-amine (Intermediate P33) (1.0 g, 1.6 mmol), 6-methoxycarbonyl-lH-indole-2- boronic acid pinacol ester (1.45 g, 4.8 mmol) , PdCUiPPhs (0.22 g, 0.32 mmol), and Na2C03 (2 N, aq) (2154) (1.6 mL, 3.2 mmol) in dioxane (23 mL) was sparged with argon and heated to 80 °C for 90 min. After cooled to rt, the reaction was diluted with water and extracted with DCM (3x). The combined organic extracts were concentrated and purified by silica chromatography (0-100% EtOAc in hexanes) to afford the title compound (958 mg, 89%). MS (apci) m/z = 672.4 (M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In 1,4-dioxane; water at 80℃; for 2h; Inert atmosphere; | Intermediate P26 (1770) (1771) Methyl 2-(6-(((tert-butyldimethylsilyl)oxy)methyl)-4-((2,4-dimethoxybenzyl)amino)-7-isopropyl-7H- pyrrolo[2,3-d1pyrimidin-5-yl)-lH-indole-6-carboxylate A mixture of 6-methoxycarbonyl-lH-indole-2-boronic acid pinacol ester (852 mg, 2.83 mmol), (1773) (PPhs)2Pd(ll)Cl2 (99.3 mg, 0.141 mmol), 6-(((tert-butyldimethylsilyl)oxy)methyl)-N-(2,4- dimethoxybenzyl)-5-iodo-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (Intermediate P14) (422 mg, 0.707 mmol) and Na2C03 (2 N aq) (707 m, 1.41 mmol) in dioxane (10 mL) was sparged with Ar and heated at 80 °C for 2 h. The reaction was partitioned between DCM and water then extracted with 4:1 DCM:IPA (3x). The combined organic extracts were concentrated and purified using silica (1774) chromatography (0-40% EtOAc in hexanes) to yield the title product (415 mg, 91%). MS (apci) m/z = 644.3 (M+H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In 1,4-dioxane at 90℃; | 1 Step 1: Preparation of methyl 2-(6-(3-(benzyloxy)-3-oxopropyl)-4-((2.4-dimethoxybenzyl)amino)-7- isopropyl-7H-pyrrolo[2.3-dlpyrimidin-5-yl)-lH-indole-6-carboxylate. A mixture of methyl 2-(4, 4,5,5- tetramethyl-l,3,2-dioxaborolan-2-yl)-lH-indole-6-carboxylate (0.318 g, 1.05 mmol), benzyl 3-(4-((2,4- dimethoxybenzyl)amino)-5-iodo-7-isopropyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)propanoate (Intermediate P16) (0.108 g, 0.176 mmol), PdCI2(PPh3)2 (0.0123 g, 0.0176 mmol) and Na2C03 (2 N, aq) (0.27 ml, 0.54 mmol) in dioxane (0.88 mL) was heated to 90 °C overnight. The reaction mixture was then filtered, concentrated and purified by silica chromatography (1-15% MeOH in DCM) to give the title compound (0.116 g, 99%). MS (apci) m/z = 662.3 (M+H). |
[ 1072944-96-7 ]
tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.72
[ 850689-27-9 ]
Methyl 3-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.72
[ 736990-02-6 ]
Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2-carboxylate
Similarity: 0.71
[ 1310405-04-9 ]
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one
Similarity: 0.67
[ 269410-24-4 ]
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
Similarity: 0.64
[ 850689-27-9 ]
Methyl 3-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.72
[ 736990-02-6 ]
Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2-carboxylate
Similarity: 0.71
[ 480425-35-2 ]
Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.64
[ 944392-68-1 ]
Dimethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalate
Similarity: 0.64
[ 171364-80-0 ]
Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Similarity: 0.63
[ 1072944-96-7 ]
tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.72
[ 736990-02-6 ]
Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2-carboxylate
Similarity: 0.71
[ 269410-24-4 ]
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
Similarity: 0.64
[ 642494-36-8 ]
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
Similarity: 0.63
[ 1219741-53-3 ]
1-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
Similarity: 0.62